Companies: 10,795·Total market cap: $144.5T
Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences

OACCNASDAQFinancial Services● Active
$10.70
+$0.05(+0.47%)
Market Cap$263035596
P/E Ratio—
52W High$10.736
52W Low$10.3
SEC Filings

Oaktree Acquisition Corp. III Life Sciences (OACC) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0002029769 · OACC · NASDAQ · as of Jun 8, 2026

Filing snapshot

55
Total Filings
SCHEDULE 13G
Latest Form
2026-05-15
Most Recent
2024
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0002029769 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-26
Fiscal Year End
Mar 26, 2026
Accession No.
0001193125-26-126536
Primary Document
d82009d10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0002029769 · Accession 0001193125-26-126536

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-13
View 10-Q on SEC
8-KCurrent Report
8-K
2025-10-29Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-15
View
10-QQuarterly Report
10-Q
2026-05-13
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-11
View
10-KAnnual Report
10-K
2026-03-26
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-11
View
10-QQuarterly Report
10-Q
2025-11-13
View
3Initial Statement of Beneficial Ownership
3
2025-10-29
View
8-KCurrent Report
8-K
2025-10-29
View
3Initial Statement of Beneficial Ownership
3
2025-10-22
View
8-KCurrent Report
8-K
2025-10-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-08-12
View
10-QQuarterly Report
10-Q
2025-08-12
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-07-15
View
3Initial Statement of Beneficial Ownership
3
2025-06-16
View
8-KCurrent Report
8-K
2025-06-06
View
Showing 1–15 of 54 filingsForm 4 / 144 hidden· 55 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0002029769  |  Exchange: NASDAQ · Financial Services

Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) has submitted 55 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2024. As a Financial Services sector company with CIK 0002029769, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Oaktree Acquisition Corp. III Life Sciences's most comprehensive regulatory disclosure. The most recent Oaktree Acquisition Corp. III Life Sciences 10-K was filed on 2026-03-26 for fiscal year ending 2026. Historical OACC 10-K annual reports are available from 2024 through 2026.

Investors researching Oaktree Acquisition Corp. III Life Sciences SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Financial Services
MBAV SEC Filings →CGCT SEC Filings →AACB SEC Filings →SOUL SEC Filings →FACT SEC Filings →PMTR SEC Filings →COPL SEC Filings →RAC SEC Filings →
→ OACC Financials→ OACC Earnings→ OACC Insider Trades

Frequently Asked Questions

OACC SEC Filings · 8 questions

Oaktree Acquisition Corp. III Life Sciences (OACC) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 55 filings and access original documents at no cost. Oaktree Acquisition Corp. III Life Sciences's CIK is 0002029769.

OACC SEC filingsOaktree Acquisition Corp. III Life Sciences SEC documentsfind OACC 10-K